This timely and clinically oriented book uniquely addresses the entire spectrum of treatment for severe obesity and diabetes. It thoroughly examines all aspects from robotic surgery to cell therapy, from the latest antidiabetic drugs to endoscopic procedures and devices, from appetite-inhibiting signals and nutrients to gastric arterial embolization. It offers objective and authoritative information for practicing professionals; not only are successful interventions discussed and updated, but cutting-edge and experimental pathways are also anticipated.
Obesity is the foremost nutritional challenge worldwide. Its companion is type-2 diabetes, the most prevalent metabolic disease. Together they represent the diabesity epidemic, which is draining resources, overwhelming healthcare facilities, and impacting life expectancy and quality of life everywhere. No country has been spared, and most medical specialties have been affected. Many books focus on the surgical options for obesity and diabetes, namely bariatric and metabolic operations. Information on the clinical and pharmacological treatment is also available, conveyed by standard texts on internal medicine and endocrinology. Yet endoscopic maneuvers and prostheses, cell therapy for diabetes, and other innovative approaches are hard to come by, as conventional texts overlook such therapies. This timely publication bridges the gaps between all different therapeutic options, also covering advances in the conservative, surgical and parasurgical domains.
This book will appeal to seasoned specialists, students and healthcare professionals in training alike.
The Dual Problem of Obesity and Diabetes: Old Problems Die Hard.- Cost of Obesity Recurrence.- Recent Trends in Bariatric and Metabolic Surgery.- Perspectives of Robotic Bariatric Surgery.- Sleeve Gastrectomy and Transit Bipartition.- Surgical Options in Type 2 Diabetes.- Endoscopic Therapeutic Options for Type 2 Diabetes.- Ileal Transposition Surgery: Mechanisms of Weight Loss and Diabetes Improvements.- Left Gastric Artery Embolization to Treat Obesity: Rationale, Technique, Experimental and Clinical Studies.- Pharmacologic Approach to Type 2 Diabetes in Obese Patients.- Peripheral Signals and Food Intake Control.- Appetite-Inhibiting Properties of Proteins.- Cell Therapy for Diabetes.- Stem Cells Derived Insulin-Secreting Cells for Insulin-Dependent Diabetes Mellitus: Exploiting Laboratory Discoveries.
Joel Faintuch is Associate Professor of Surgery, São Paulo University Medical School, Head of the Nutrology Residency Program, Hospital das Clinicas, Sao Paulo, and Editor-in-Chief, Brazilian Journal of Clinical Nutrition. He was Executive Director of the Brazilian Society of Bariatric and Metabolic Surgery (1999-2002) and is currently Associated Editor, Obesity Surgery (USA). Joel Faintuch is a former International Guest Scholar, American College of Surgeons, USA and Honorary Member of three international societies (SBNPE, FELANPE and SBCBM). Salomao Faintuch is Assistant Professor of Radiology, Harvard Medical School, and Staff Radiologist in Vascular & Interventional Radiology, Beth Israel Deaconess Medical Center, Boston, USA. He was Research Scholar of the Radiological Society of North America/RSNA, 2008-2010, and is currently Chairman, RSNA Daily Bulletin Editorial Board, RSNA Public Information Committee. He has been active in a variety of research projects, including gastrointestinal surgery and minimally invasive procedures, and serves on the Editorial Board of specialty journals.